Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "GENE RE-ARRANGEMENTS" patented technology

Method for preparing endothelial progenitor cell capturing bracket for gene modification and regulation

The invention provides a method for preparing an endothelial progenitor cell capturing bracket for gene modification and regulation, which comprises the following steps: 1, preprocessing a bare bracket; 2, preparing an endothelial progenitor cell antibody bracket; 3, combining Caspase genes and specific promoter gene segments differentiated from smooth muscle cells in a gene recombination way and then combining the composition of the Caspase genes and the specific promoter gene segments and eukaryotic expression vectors pEGFPC2 or pcDNA3.1 in the gene recombination way to obtain fusion genes; and 4, dissolving the fusion genes obtained in the step 3 in de-ionized water solution to obtain solution of which the concentration of the fusion genes is 10 to 100 mg / ml, placing the endothelial progenitor cell antibody bracket obtained in the step 2 into the solution for co-incubation at 4 DEG C for 12 minutes, taking the endothelial progenitor cell antibody bracket out, naturally airing the endothelial progenitor cell antibody bracket in a super clean bench for 2 to 6 hours and storing the endothelial progenitor cell antibody bracket at 4 DEG C. The method has the advantages of dual functions of resisting restenosis and protecting endothelial repair.
Owner:上海中山医疗科技发展有限公司 +1

Building method and application of lactobacillus reuteri resistance-marker-free gene integration system

The invention discloses a building method and application of a lactobacillus reuteri resistance-marker-free gene integration system. By means of the point mutation technology, a point mutation gene pheSM of a lactobacillus reuteri pheS gene is obtained, the point mutation gene pheSM and a erythromycin resistance gene are used for building an integrated framework LR-pheSM-em-RR, the integrated framework LR-pheSM-em-RR is electrically converted into L.renteri XNY competent cells, and pheSM genetic recombination lactobacillus L.renteri XNYM is obtained through erythromycin screening; then, the gene integration framework is constructed and inserted, then the gene integration framework is electrically converted into pheSM gene recombination lactobacillus reuteri competent cells, and the lactobacillus reuteri without resistance markers can be obtained through para-chlorophenylalanine acid resistance screening. According to the method, resistance genes are not introduced into host bacteria genomes, so that biological safety hidden hazards of the resistance genes and the polarity effect of the resistance genes on upstream genes and downstream genes are avoided. By means of the system, gene targeted integration can be carried out on the host bacteria for multiple times.
Owner:NORTHWEST A & F UNIV

Interface-controllable material gene recombination blending modification technology

The invention provides an interface-controllable material gene recombination blending modification technology. The technology mainly comprises a material gene recombination multi-unit plasticizing extrusion device, a stretching device, a double-screw blending device and a granulation device. The technology is based on a material gene recombination principle, various monomer materials are combined and matched in advance according to given relative positions and proportions, and the preparation technology is combined, so that the proportion and the interface state of the multi-component materials are controlled, and the gene recombination composite material with specific performance is obtained. According to the specific implementation mode, firstly, monomer materials are combined and co-extruded according to the given relative position and proportion through a material gene recombination multi-unit plasticizing extrusion device, after extrusion, the composite material of the multi-layer structure is obtained, the interface layers of the monomer materials of each layer are distinct, then the composite material structure is stretched and refined through a differential roller in a stretching device, and finally the composite material is obtained. Then, a composite material with specific performance is obtained under the plasticizing action of a double-screw blending device, and finally, granules are obtained through a granulating device.
Owner:BEIJING UNIV OF CHEM TECH

A method for establishing a Lactobacillus reuteri non-resistance marker gene integration system and its application

The invention discloses a building method and application of a lactobacillus reuteri resistance-marker-free gene integration system. By means of the point mutation technology, a point mutation gene pheSM of a lactobacillus reuteri pheS gene is obtained, the point mutation gene pheSM and a erythromycin resistance gene are used for building an integrated framework LR-pheSM-em-RR, the integrated framework LR-pheSM-em-RR is electrically converted into L.renteri XNY competent cells, and pheSM genetic recombination lactobacillus L.renteri XNYM is obtained through erythromycin screening; then, the gene integration framework is constructed and inserted, then the gene integration framework is electrically converted into pheSM gene recombination lactobacillus reuteri competent cells, and the lactobacillus reuteri without resistance markers can be obtained through para-chlorophenylalanine acid resistance screening. According to the method, resistance genes are not introduced into host bacteria genomes, so that biological safety hidden hazards of the resistance genes and the polarity effect of the resistance genes on upstream genes and downstream genes are avoided. By means of the system, gene targeted integration can be carried out on the host bacteria for multiple times.
Owner:NORTHWEST A & F UNIV

African green monkey kidney cell line capable of stably expressing SLAM protein as well as construction method and application of African green monkey kidney cell line

PendingCN114214268ADoes not affect normal physiological functionAchieve normal expressionImmunoglobulin superfamilyGenetically modified cellsSLAM ProteinCanine distemper virus CDV
The invention belongs to the technical field of gene recombination and protein expression, and particularly relates to an African green monkey kidney cell line capable of stably expressing SLAM protein as well as a construction method and application of the African green monkey kidney cell line, the cell line is African green monkey kidney cells Vero-E6-SLAM, the African green monkey kidney cells Vero-E6-SLAM are sent to Guangdong Microbial Culture Collection Center on November 11, 2021 to be preserved, and the preservation number is GDMCCNO: 62054. The preparation method comprises the following steps: constructing a pAAVS1-Donor-SLAM overexpression plasmid, and then co-transfecting the pAAVS1-Donor-SLAM overexpression plasmid and pCass-Guide-AAVS1 into a Vero-E6 cell, so as to obtain the recombinant vector. According to the cell line, an exogenous gene can be integrated into a known safe site in a genome, normal expression of the transferred gene is realized without influencing the normal physiological function of the cell, the cloning accuracy is high, the cell line can be applied to high-yield SLAM protein, and a platform is provided for separation and pathogenic mechanism research of canine distemper virus.
Owner:INST OF ANIMAL HEALTH GUANGDONG ACADEMY OF AGRI SCI

Preparation method of gene recombinant collagen oligopeptide

The invention discloses a preparation method of gene recombinant collagen oligopeptide. The preparation method of the gene recombinant collagen oligopeptide comprises the following steps: S1, synthesizing an MYS-1 gene by adopting a pair of complementary primers through PCR (Polymerase Chain Reaction); s2, carrying out double enzyme digestion on the MYS-1 gene to obtain a recombinant plasmid; s3, transforming expression host escherichia coli by using the recombinant plasmid to obtain expression engineering bacteria; s4, inducing the expression engineering bacteria to express fusion protein; s5, performing purification: collecting an eluent; s6, enzyme digestion of the fusion protein and purification of a target polypeptide MYS-1; and S7, purifying and preparing the collagen oligopeptide MYS-1 by using a high performance liquid chromatography technology to obtain the high-purity gene recombinant high-stability collagen oligopeptide MYS-1. The length of the prepared collagen oligopeptide is far smaller than that of natural human collagen and related hydrolyzed polypeptide, the collagen oligopeptide is small in molecular weight, easy to prepare and high in efficiency, and the collagen oligopeptide has good biological activities such as oxidation resistance, aging resistance, repair promotion and melanogenesis inhibition.
Owner:广州星途投资运营集团有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products